French drugmaker Sanofi on Monday said the COVID-19 vaccine candidate it has developed jointly with GSK in two trials showed a potential to protect against the virus’s main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster jab....
At the Steenbock Symposium on June 7 and 8, 2022, the University of Wisconsin–Madison Department of Biochemistry opened its doors in celebration of two new research centers that bring to campus advanced biomolecular imaging technology called cryo-electron microscopy....
The finding has implications for future treatment of retinal diseases that cause blindness, including age-related macular degeneration and rare diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and Best disease. People living with these...
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The Food and Drug Administration’s action follows its advisory panel’s unanimous recommendation for...
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The Food and Drug Administration’s action follows its advisory panel’s unanimous recommendation for...